Detalhe da pesquisa
1.
A pH-responsive crosslinker platform for antibody-drug conjugate (ADC) targeting delivery.
Chem Commun (Camb);
58(75): 10532-10535, 2022 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36043993
2.
The Pyrazolo[3,4-d]Pyrimidine Derivative Si306 Encapsulated into Anti-GD2-Immunoliposomes as Therapeutic Treatment of Neuroblastoma.
Biomedicines;
10(3)2022 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35327462
3.
Focused library of phenyl-fused macrocyclic amidinoureas as antifungal agents.
Mol Divers;
26(6): 3399-3409, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35143033
4.
Antibacterial alkylguanidino ureas: Molecular simplification approach, searching for membrane-based MoA.
Eur J Med Chem;
231: 114158, 2022 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35168113
5.
Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIß) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus, and Human Rhinoviruses.
ChemMedChem;
16(23): 3548-3552, 2021 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34382337
6.
Si113-prodrugs selectively activated by plasmin against hepatocellular and ovarian carcinoma.
Eur J Med Chem;
223: 113653, 2021 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34161866
7.
AuNP Pyrazolo[3,4-d]pyrimidine Nanosystem in Combination with Radiotherapy against Glioblastoma.
ACS Med Chem Lett;
11(5): 664-670, 2020 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32435368
8.
A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor.
Cancers (Basel);
11(6)2019 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31248184